{"transactions":[{"id":767404,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-05-21T20:12:16.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":10539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2027 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date."}],"balance_after":10539,"derivative":{"exercise_price":5.08,"expiration_date":"2036-05-19","underlying":"Common Stock","underlying_shares":10539},"source":{"system":"sec-edgar","filing":"0001677141-26-000006","document":"form4-05212026_080513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000006/form4-05212026_080513.xml","form_type":"4"}},{"id":928747,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-29T01:19:26.000Z","date":"2026-01-26","kind":"sale","planned":true,"acquired":false,"shares":3746,"price":37.152,"value":139171.392,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.57 to $37.70. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person's previous Form 4 filed on January 26, 2026 inadvertently misstated the number of shares of common stock beneficially owned following the transactions reported therein, and that the number has been corrected in the current filing."}],"balance_after":24521,"source":{"system":"sec-edgar","filing":"0001677141-26-000004","document":"form4-01292026_010123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000004/form4-01292026_010123.xml","form_type":"4"}},{"id":931008,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T21:49:02.000Z","date":"2026-01-25","kind":"exercise","planned":false,"acquired":false,"shares":4725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":14175,"derivative":{"underlying":"Common Stock","underlying_shares":4725},"source":{"system":"sec-edgar","filing":"0001677141-26-000002","document":"form4-01262026_090157.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000002/form4-01262026_090157.xml","form_type":"4"}},{"id":931007,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T21:49:02.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":false,"shares":3813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":7625,"derivative":{"underlying":"Common Stock","underlying_shares":3813},"source":{"system":"sec-edgar","filing":"0001677141-26-000002","document":"form4-01262026_090157.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000002/form4-01262026_090157.xml","form_type":"4"}},{"id":931006,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T21:49:02.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":12200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":12200,"derivative":{"underlying":"Common Stock","underlying_shares":12200},"source":{"system":"sec-edgar","filing":"0001677141-26-000002","document":"form4-01262026_090157.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000002/form4-01262026_090157.xml","form_type":"4"}},{"id":931005,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option","published_at":"2026-01-26T21:49:02.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":42600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":42600,"derivative":{"exercise_price":36.76,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":42600},"source":{"system":"sec-edgar","filing":"0001677141-26-000002","document":"form4-01262026_090157.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000002/form4-01262026_090157.xml","form_type":"4"}},{"id":931004,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T21:49:02.000Z","date":"2026-01-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":2553,"price":36.82,"value":94001.46,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":2172,"source":{"system":"sec-edgar","filing":"0001677141-26-000002","document":"form4-01262026_090157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000002/form4-01262026_090157.xml","form_type":"4"}},{"id":931003,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T21:49:02.000Z","date":"2026-01-25","kind":"exercise","planned":false,"acquired":true,"shares":4725,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4725,"source":{"system":"sec-edgar","filing":"0001677141-26-000002","document":"form4-01262026_090157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000002/form4-01262026_090157.xml","form_type":"4"}},{"id":931002,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T21:49:02.000Z","date":"2026-01-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":36.82,"value":82439.98,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":1574,"source":{"system":"sec-edgar","filing":"0001677141-26-000002","document":"form4-01262026_090157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000002/form4-01262026_090157.xml","form_type":"4"}},{"id":931001,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T21:49:02.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":true,"shares":3813,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3813,"source":{"system":"sec-edgar","filing":"0001677141-26-000002","document":"form4-01262026_090157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000002/form4-01262026_090157.xml","form_type":"4"}},{"id":935004,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-21T01:39:14.000Z","date":"2026-01-15","kind":"sale","planned":true,"acquired":false,"shares":20961,"price":35.9159,"value":752833.1799,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.68 to $36.10. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001677141-26-000001","document":"form4-01212026_010111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000001/form4-01212026_010111.xml","form_type":"4"}},{"id":975513,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option","published_at":"2025-12-09T21:10:06.000Z","date":"2025-12-05","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest with respect to 50% of the underlying shares on March 23, 2023 and with respect to the remaining shares, in twenty-four equal monthly installments beginning on April 23, 2023."}],"balance_after":185000,"derivative":{"exercise_price":29.03,"expiration_date":"2031-03-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001677141-25-000008","document":"form4-12092025_041201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714125000008/form4-12092025_041201.xml","form_type":"4"}},{"id":975512,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-09T21:10:06.000Z","date":"2025-12-05","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":39.5448,"value":790896.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $39.63. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001677141-25-000008","document":"form4-12092025_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714125000008/form4-12092025_041201.xml","form_type":"4"}},{"id":975511,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-09T21:10:06.000Z","date":"2025-12-05","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":29.03,"value":580600.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001677141-25-000008","document":"form4-12092025_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714125000008/form4-12092025_041201.xml","form_type":"4"}},{"id":988347,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-11-25T21:10:07.000Z","date":"2025-11-21","kind":"sale","planned":true,"acquired":false,"shares":3427,"price":35,"value":119945.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001677141-25-000006","document":"form4-11252025_041102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714125000006/form4-11252025_041102.xml","form_type":"4"}},{"id":1026470,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-10-02T20:05:07.000Z","date":"2025-09-30","kind":"exercise","planned":false,"acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":45000,"derivative":{"underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001677141-25-000004","document":"form4-10022025_041003.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714125000004/form4-10022025_041003.xml","form_type":"4"}},{"id":1026469,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-10-02T20:05:07.000Z","date":"2025-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":24039,"price":27.56,"value":662514.84,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":20961,"source":{"system":"sec-edgar","filing":"0001677141-25-000004","document":"form4-10022025_041003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714125000004/form4-10022025_041003.xml","form_type":"4"}},{"id":1026468,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-10-02T20:05:07.000Z","date":"2025-09-30","kind":"exercise","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":45000,"source":{"system":"sec-edgar","filing":"0001677141-25-000004","document":"form4-10022025_041003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714125000004/form4-10022025_041003.xml","form_type":"4"}},{"id":1061127,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-08-19T20:15:07.000Z","date":"2025-08-15","kind":"sale","planned":true,"acquired":false,"shares":21573,"price":36.4983,"value":787377.8259,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.11 to $36.87. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-022294","document":"form4-08192025_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588925022294/form4-08192025_040801.xml","form_type":"4"}},{"id":1128875,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-05-31T01:41:02.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":201857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2026 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date."}],"balance_after":201857,"derivative":{"exercise_price":0.3598,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":201857},"source":{"system":"sec-edgar","filing":"0001415889-25-015077","document":"form4-05312025_010556.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588925015077/form4-05312025_010556.xml","form_type":"4"}},{"id":1178692,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-04-03T20:15:17.000Z","date":"2025-04-01","kind":"sale","planned":true,"acquired":false,"shares":740,"price":33.1152,"value":24505.248,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.02 to $33.22. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-009936","document":"form4-04032025_040408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588925009936/form4-04032025_040408.xml","form_type":"4"}},{"id":1178691,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-04-03T20:15:17.000Z","date":"2025-04-01","kind":"sale","planned":true,"acquired":false,"shares":6247,"price":32.4765,"value":202880.6955,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $33.01. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":740,"source":{"system":"sec-edgar","filing":"0001415889-25-009936","document":"form4-04032025_040408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588925009936/form4-04032025_040408.xml","form_type":"4"}},{"id":1185908,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-04-01T20:10:05.000Z","date":"2025-03-29","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This award of restricted stock units was previously granted on March 29, 2021. 50% of the underlying shares vested on March 29, 2023. 25% of the underlying shares are scheduled to vest on each of  March 29, 2024 and March 29, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award of restricted stock units was previously granted on March 29, 2021. 50% of the underlying shares vested on March 29, 2023. 25% of the underlying shares are scheduled to vest on each of  March 29, 2024 and March 29, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award of restricted stock units was previously granted on March 29, 2021. 50% of the underlying shares vested on March 29, 2023. 25% of the underlying shares are scheduled to vest on each of  March 29, 2024 and March 29, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":15000,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-25-009357","document":"form4-04012025_040402.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588925009357/form4-04012025_040402.xml","form_type":"4"}},{"id":1185907,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-04-01T20:10:05.000Z","date":"2025-03-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":8014,"price":33.19,"value":265984.66,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":6986,"source":{"system":"sec-edgar","filing":"0001415889-25-009357","document":"form4-04012025_040402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588925009357/form4-04012025_040402.xml","form_type":"4"}},{"id":1185906,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-04-01T20:10:05.000Z","date":"2025-03-29","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001415889-25-009357","document":"form4-04012025_040402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588925009357/form4-04012025_040402.xml","form_type":"4"}},{"id":1292791,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-01-28T21:04:45.000Z","date":"2025-01-25","kind":"grant","planned":true,"acquired":true,"shares":18900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":". The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":". The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":". The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":18900,"derivative":{"underlying":"Common Stock","underlying_shares":18900},"source":{"system":"sec-edgar","filing":"0001415889-25-002158","document":"form4-01282025_090140.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588925002158/form4-01282025_090140.xml","form_type":"4"}},{"id":1292790,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option","published_at":"2025-01-28T21:04:45.000Z","date":"2025-01-25","kind":"grant","planned":true,"acquired":true,"shares":66250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests with respect to 25% of the underlying shares on January 25, 2026, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":66250,"derivative":{"exercise_price":38.01,"expiration_date":"2035-01-25","underlying":"Common Stock","underlying_shares":66250},"source":{"system":"sec-edgar","filing":"0001415889-25-002158","document":"form4-01282025_090140.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588925002158/form4-01282025_090140.xml","form_type":"4"}},{"id":1292789,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-01-28T21:04:45.000Z","date":"2025-01-24","kind":"exercise","planned":true,"acquired":false,"shares":3812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":11438,"derivative":{"underlying":"Common Stock","underlying_shares":3812},"source":{"system":"sec-edgar","filing":"0001415889-25-002158","document":"form4-01282025_090140.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588925002158/form4-01282025_090140.xml","form_type":"4"}},{"id":1292788,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-28T21:04:45.000Z","date":"2025-01-27","kind":"sale","planned":true,"acquired":false,"shares":1775,"price":38.0548,"value":67547.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.80 to $38.68. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-002158","document":"form4-01282025_090140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588925002158/form4-01282025_090140.xml","form_type":"4"}},{"id":1292787,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-28T21:04:45.000Z","date":"2025-01-24","kind":"tax_withholding","planned":true,"acquired":false,"shares":2037,"price":38.01,"value":77426.37,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":1775,"source":{"system":"sec-edgar","filing":"0001415889-25-002158","document":"form4-01282025_090140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588925002158/form4-01282025_090140.xml","form_type":"4"}},{"id":1292786,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-28T21:04:45.000Z","date":"2025-01-24","kind":"exercise","planned":true,"acquired":true,"shares":3812,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3812,"source":{"system":"sec-edgar","filing":"0001415889-25-002158","document":"form4-01282025_090140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588925002158/form4-01282025_090140.xml","form_type":"4"}},{"id":1296150,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option","published_at":"2025-01-23T21:15:09.000Z","date":"2025-01-21","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest with respect to 50% of the underlying shares on March 23, 2023 and with respect to the remaining shares, in twenty-four equal monthly installments beginning on April 23, 2023."}],"balance_after":205000,"derivative":{"exercise_price":29.03,"expiration_date":"2031-03-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-25-001925","document":"form4-01232025_090105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588925001925/form4-01232025_090105.xml","form_type":"4"}},{"id":1296149,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-23T21:15:09.000Z","date":"2025-01-21","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":40.1839,"value":1004597.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.53. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-001925","document":"form4-01232025_090105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588925001925/form4-01232025_090105.xml","form_type":"4"}},{"id":1296148,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-23T21:15:09.000Z","date":"2025-01-21","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":29.03,"value":725750.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001415889-25-001925","document":"form4-01232025_090105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588925001925/form4-01232025_090105.xml","form_type":"4"}},{"id":1393667,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-10-02T20:04:07.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This award of restricted stock units was previously granted on October 4, 2023. 40% of the underlying shares vested on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award of restricted stock units was previously granted on October 4, 2023. 40% of the underlying shares vested on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award of restricted stock units was previously granted on October 4, 2023. 40% of the underlying shares vested on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":90000,"derivative":{"underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001415889-24-024357","document":"form4-10022024_081004.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588924024357/form4-10022024_081004.xml","form_type":"4"}},{"id":1393666,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-02T20:04:07.000Z","date":"2024-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":32052,"price":40,"value":1282080.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":27948,"source":{"system":"sec-edgar","filing":"0001415889-24-024357","document":"form4-10022024_081004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588924024357/form4-10022024_081004.xml","form_type":"4"}},{"id":1393665,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-02T20:04:07.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001415889-24-024357","document":"form4-10022024_081004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588924024357/form4-10022024_081004.xml","form_type":"4"}},{"id":1503208,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2024-05-23T20:55:06.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":47693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2025 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date."}],"balance_after":47693,"derivative":{"exercise_price":1.28,"expiration_date":"2034-05-21","underlying":"Common Stock","underlying_shares":47693},"source":{"system":"sec-edgar","filing":"0001415889-24-014312","document":"form4-05232024_080500.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588924014312/form4-05232024_080500.xml","form_type":"4"}},{"id":1552612,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-04-02T20:31:06.000Z","date":"2024-03-29","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This award of restricted stock units was previously granted on March 29, 2021. 50% of the underlying shares vested on March 29, 2023 and 25% of the shares vested on March 29, 2024, with the remaining 25% of the underlying shares scheduled to vest on March 29, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award of restricted stock units was previously granted on March 29, 2021. 50% of the underlying shares vested on March 29, 2023 and 25% of the shares vested on March 29, 2024, with the remaining 25% of the underlying shares scheduled to vest on March 29, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award of restricted stock units was previously granted on March 29, 2021. 50% of the underlying shares vested on March 29, 2023 and 25% of the shares vested on March 29, 2024, with the remaining 25% of the underlying shares scheduled to vest on March 29, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":15000,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-24-009781","document":"form4-04022024_040442.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588924009781/form4-04022024_040442.xml","form_type":"4"}},{"id":1552611,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-04-02T20:31:06.000Z","date":"2024-03-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":8013,"price":33.58,"value":269076.54,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":6987,"source":{"system":"sec-edgar","filing":"0001415889-24-009781","document":"form4-04022024_040442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588924009781/form4-04022024_040442.xml","form_type":"4"}},{"id":1552610,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-04-02T20:31:06.000Z","date":"2024-03-29","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001415889-24-009781","document":"form4-04022024_040442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588924009781/form4-04022024_040442.xml","form_type":"4"}},{"id":1669213,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-01-26T21:53:26.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":15250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":15250,"derivative":{"underlying":"Common Stock","underlying_shares":15250},"source":{"system":"sec-edgar","filing":"0001415889-24-001869","document":"form4-01262024_090119.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588924001869/form4-01262024_090119.xml","form_type":"4"}},{"id":1669212,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option","published_at":"2024-01-26T21:53:26.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":74250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":74250,"derivative":{"exercise_price":30.69,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":74250},"source":{"system":"sec-edgar","filing":"0001415889-24-001869","document":"form4-01262024_090119.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588924001869/form4-01262024_090119.xml","form_type":"4"}},{"id":1746482,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2023-11-08T21:00:34.000Z","date":"2023-10-04","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":150000,"derivative":{"exercise_price":31.78,"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-23-014888","document":"form4-11082023_091127.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588923014888/form4-11082023_091127.xml","form_type":"4"}},{"id":1875867,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-05-26T20:34:00.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of:  (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2024 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date."}],"balance_after":24000,"derivative":{"exercise_price":1,"expiration_date":"2033-05-24","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-23-032565","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000120919123032565/doc4.xml","form_type":"4"}},{"id":1933733,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2023-03-31T20:26:10.000Z","date":"2023-03-29","kind":"exercise","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This award of restricted stock units was previously granted on March 29, 2021. 50% of the underlying shares vested on March 29, 2023. 25% of the underlying shares are scheduled to vest on each of  March 29, 2024 and March 29, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award of restricted stock units was previously granted on March 29, 2021. 50% of the underlying shares vested on March 29, 2023. 25% of the underlying shares are scheduled to vest on each of  March 29, 2024 and March 29, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award of restricted stock units was previously granted on March 29, 2021. 50% of the underlying shares vested on March 29, 2023. 25% of the underlying shares are scheduled to vest on each of  March 29, 2024 and March 29, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":30000,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-23-005668","document":"form4-03312023_080303.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588923005668/form4-03312023_080303.xml","form_type":"4"}},{"id":1933732,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2023-03-31T20:26:10.000Z","date":"2023-03-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":15414,"price":33.36,"value":514211.04,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":14586,"source":{"system":"sec-edgar","filing":"0001415889-23-005668","document":"form4-03312023_080303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588923005668/form4-03312023_080303.xml","form_type":"4"}},{"id":1933731,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2023-03-31T20:26:10.000Z","date":"2023-03-29","kind":"exercise","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001415889-23-005668","document":"form4-03312023_080303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588923005668/form4-03312023_080303.xml","form_type":"4"}},{"id":2097730,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-02T22:14:35.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":5000,"price":1.1929,"value":5964.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.17 to $1.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-059462","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000120919122059462/doc4.xml","form_type":"4"}},{"id":2250826,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-05-31T20:28:32.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of:  (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date."}],"balance_after":24000,"derivative":{"exercise_price":1.76,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-22-032825","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000120919122032825/doc4.xml","form_type":"4"}},{"id":2690624,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-05-28T22:01:19.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":16918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as of 1/12 of the total shares monthly beginning on June 27, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":16918,"derivative":{"exercise_price":13.83,"expiration_date":"2031-05-26","underlying":"Common Stock","underlying_shares":16918},"source":{"system":"sec-edgar","filing":"0001209191-21-036625","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000120919121036625/doc4.xml","form_type":"4"}},{"id":2765932,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2021-03-31T20:08:06.000Z","date":"2021-03-29","kind":"grant","acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests with respect to 50% of the underlying shares on March 29, 2023, and will vest with respect to the remainder of the shares in 24 equal monthly installments thereafter."}],"balance_after":230000,"derivative":{"exercise_price":29.03,"expiration_date":"2031-03-29","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0000899243-21-014161","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000089924321014161/doc4.xml","form_type":"4"}},{"id":2765931,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-03-31T20:08:06.000Z","date":"2021-03-29","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents an award of restricted stock units, which will vest with respect to 50% of the underlying shares on March 29, 2023, and in two equal annual installments thereafter. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of restricted stock units, which will vest with respect to 50% of the underlying shares on March 29, 2023, and in two equal annual installments thereafter. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents an award of restricted stock units, which will vest with respect to 50% of the underlying shares on March 29, 2023, and in two equal annual installments thereafter. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":60000,"derivative":{"underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-21-014161","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000089924321014161/doc4.xml","form_type":"4"}},{"id":2895007,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Option to Purchase Common Stock","published_at":"2021-01-26T19:01:50.000Z","date":"2021-01-22","kind":"grant","acquired":true,"shares":26900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2021."}],"balance_after":26900,"derivative":{"exercise_price":29.46,"expiration_date":"2031-01-22","underlying":"Common Stock","underlying_shares":26900},"source":{"system":"sec-edgar","filing":"0001104659-21-007782","document":"tm214232-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921007782/tm214232-5_4seq1.xml","form_type":"4"}},{"id":2895006,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2021-01-26T19:01:50.000Z","date":"2021-01-22","kind":"grant","acquired":true,"shares":17200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2021."}],"balance_after":40964,"source":{"system":"sec-edgar","filing":"0001104659-21-007782","document":"tm214232-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921007782/tm214232-5_4seq1.xml","form_type":"4"}},{"id":2919925,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2021-01-05T19:01:15.000Z","date":"2021-01-05","kind":"sale","acquired":false,"shares":2193,"price":24.47,"value":53662.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":23764,"source":{"system":"sec-edgar","filing":"0001104659-21-001123","document":"tm211606-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921001123/tm211606-5_4seq1.xml","form_type":"4"}},{"id":2919924,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2021-01-05T19:01:15.000Z","date":"2021-01-01","kind":"tax_withholding","acquired":false,"shares":342,"price":24.7,"value":8447.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock and restricted stock unit awards previously granted to the reporting person."}],"balance_after":25957,"source":{"system":"sec-edgar","filing":"0001104659-21-001123","document":"tm211606-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921001123/tm211606-5_4seq1.xml","form_type":"4"}},{"id":2919923,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2021-01-05T19:01:15.000Z","date":"2020-12-31","kind":"tax_withholding","acquired":false,"shares":859,"price":24.7,"value":21217.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person."}],"balance_after":26299,"source":{"system":"sec-edgar","filing":"0001104659-21-001123","document":"tm211606-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921001123/tm211606-5_4seq1.xml","form_type":"4"}},{"id":2942236,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2020-12-16T19:00:32.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":1763,"price":32.78,"value":57791.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":27158,"source":{"system":"sec-edgar","filing":"0001104659-20-136448","document":"tm2038708d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920136448/tm2038708d1_4.xml","form_type":"4"}},{"id":3012868,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2020-10-05T19:00:46.000Z","date":"2020-10-01","kind":"tax_withholding","acquired":false,"shares":296,"price":42.08,"value":12455.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock and restricted stock unit awards previously granted to the reporting person."}],"balance_after":28921,"source":{"system":"sec-edgar","filing":"0001104659-20-112317","document":"tm2032461d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920112317/tm2032461d2_4.xml","form_type":"4"}},{"id":3088512,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2020-07-06T19:01:58.000Z","date":"2020-07-01","kind":"tax_withholding","acquired":false,"shares":615,"price":46.52,"value":28609.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock and restricted stock unit awards previously granted to the reporting person."}],"balance_after":29217,"source":{"system":"sec-edgar","filing":"0001104659-20-081438","document":"tm2024073d5_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920081438/tm2024073d5_4.xml","form_type":"4"}},{"id":3182786,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2020-04-03T19:05:37.000Z","date":"2020-04-01","kind":"tax_withholding","acquired":false,"shares":615,"price":58.4,"value":35916.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock and restricted stock unit awards previously granted to the reporting person."}],"balance_after":29832,"source":{"system":"sec-edgar","filing":"0001104659-20-043287","document":"tm2014981d5_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920043287/tm2014981d5_4.xml","form_type":"4"}},{"id":3230543,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-03T23:43:26.000Z","date":"2020-03-03","kind":"purchase","acquired":true,"shares":5000,"price":18,"value":90000.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-20-015628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000120919120015628/doc4.xml","form_type":"4"}},{"id":3237136,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-03-02T22:56:48.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":16918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vest as to 2.778% of the total shares monthly, commencing March 27, 2020, with 100% of the total shares vested on February 27, 2023, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":16918,"derivative":{"exercise_price":18,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":16918},"source":{"system":"sec-edgar","filing":"0001209191-20-014698","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000120919120014698/doc4.xml","form_type":"4"}},{"id":3301192,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Option to Purchase Common Stock","published_at":"2020-01-27T19:06:07.000Z","date":"2020-01-23","kind":"grant","acquired":true,"shares":9200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2020."}],"balance_after":9200,"derivative":{"exercise_price":99.66,"expiration_date":"2030-01-23","underlying":"Common Stock","underlying_shares":9200},"source":{"system":"sec-edgar","filing":"0001104659-20-007266","document":"tm205922d7_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920007266/tm205922d7_4.xml","form_type":"4"}},{"id":3301191,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2020-01-27T19:06:07.000Z","date":"2020-01-23","kind":"grant","acquired":true,"shares":5600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2020."}],"balance_after":30447,"source":{"system":"sec-edgar","filing":"0001104659-20-007266","document":"tm205922d7_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920007266/tm205922d7_4.xml","form_type":"4"}},{"id":3322386,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2020-01-03T19:00:52.000Z","date":"2020-01-01","kind":"tax_withholding","acquired":false,"shares":669,"price":123.92,"value":82902.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock and restricted stock unit awards previously granted to the reporting person."}],"balance_after":24847,"source":{"system":"sec-edgar","filing":"0001104659-20-001091","document":"tm201209d8_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920001091/tm201209d8_4.xml","form_type":"4"}},{"id":3322385,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2020-01-03T19:00:52.000Z","date":"2019-12-31","kind":"tax_withholding","acquired":false,"shares":551,"price":123.92,"value":68279.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":25516,"source":{"system":"sec-edgar","filing":"0001104659-20-001091","document":"tm201209d8_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920001091/tm201209d8_4.xml","form_type":"4"}},{"id":3398292,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2019-10-03T19:00:23.000Z","date":"2019-10-01","kind":"tax_withholding","acquired":false,"shares":626,"price":65.87,"value":41234.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock and restricted stock unit awards previously granted to the reporting person."}],"balance_after":26067,"source":{"system":"sec-edgar","filing":"0001144204-19-047218","document":"tv530559_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419047218/tv530559_4.xml","form_type":"4"}},{"id":3467708,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2019-07-03T17:00:41.000Z","date":"2019-07-01","kind":"tax_withholding","acquired":false,"shares":615,"price":79.17,"value":48689.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock and restricted stock unit awards previously granted to the reporting person."}],"balance_after":26693,"source":{"system":"sec-edgar","filing":"0001144204-19-033816","document":"tv524735_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419033816/tv524735_form4.xml","form_type":"4"}},{"id":3564218,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2019-04-03T19:00:25.000Z","date":"2019-04-01","kind":"tax_withholding","acquired":false,"shares":615,"price":111.5,"value":68572.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock and restricted stock unit awards previously granted to the reporting person."}],"balance_after":27308,"source":{"system":"sec-edgar","filing":"0001144204-19-018079","document":"tv517925_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419018079/tv517925_4.xml","form_type":"4"}},{"id":3691642,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Option to Purchase Common Stock","published_at":"2019-01-18T19:03:05.000Z","date":"2019-01-16","kind":"grant","acquired":true,"shares":7200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2019."}],"balance_after":7200,"derivative":{"exercise_price":110.8,"expiration_date":"2029-01-16","underlying":"Common Stock","underlying_shares":7200},"source":{"system":"sec-edgar","filing":"0001144204-19-002140","document":"tv511181_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419002140/tv511181_4.xml","form_type":"4"}},{"id":3691641,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2019-01-18T19:03:05.000Z","date":"2019-01-16","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2019."}],"balance_after":27923,"source":{"system":"sec-edgar","filing":"0001144204-19-002140","document":"tv511181_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419002140/tv511181_4.xml","form_type":"4"}},{"id":3708147,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2019-01-03T19:02:40.000Z","date":"2019-01-01","kind":"tax_withholding","acquired":false,"shares":1118,"price":100.79,"value":112683.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock and restricted stock units."}],"balance_after":23423,"source":{"system":"sec-edgar","filing":"0001144204-19-000499","document":"tv510190_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419000499/tv510190_form4.xml","form_type":"4"}},{"id":3798300,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2018-10-03T19:01:45.000Z","date":"2018-10-01","kind":"tax_withholding","acquired":false,"shares":531,"price":126.46,"value":67150.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the amount of securities beneficially owned following the reported transactions is provided as of the date of this Form 4."}],"balance_after":24541,"source":{"system":"sec-edgar","filing":"0001144204-18-052406","document":"tv503774_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418052406/tv503774_4.xml","form_type":"4"}},{"id":3798299,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2018-10-03T19:01:45.000Z","date":"2018-07-01","kind":"tax_withholding","acquired":false,"shares":468,"price":83.91,"value":39269.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the amount of securities beneficially owned following the reported transactions is provided as of the date of this Form 4."}],"balance_after":24541,"source":{"system":"sec-edgar","filing":"0001144204-18-052406","document":"tv503774_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418052406/tv503774_4.xml","form_type":"4"}},{"id":3798298,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2018-10-03T19:01:45.000Z","date":"2018-04-01","kind":"tax_withholding","acquired":false,"shares":468,"price":61.52,"value":28791.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the amount of securities beneficially owned following the reported transactions is provided as of the date of this Form 4."}],"balance_after":24541,"source":{"system":"sec-edgar","filing":"0001144204-18-052406","document":"tv503774_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418052406/tv503774_4.xml","form_type":"4"}},{"id":3798297,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2018-10-03T19:01:45.000Z","date":"2018-01-01","kind":"tax_withholding","acquired":false,"shares":1107,"price":58.42,"value":64670.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the amount of securities beneficially owned following the reported transactions is provided as of the date of this Form 4."}],"balance_after":24541,"source":{"system":"sec-edgar","filing":"0001144204-18-052406","document":"tv503774_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418052406/tv503774_4.xml","form_type":"4"}},{"id":4039912,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2018-02-22T21:00:34.000Z","date":"2018-02-05","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares of common stock underlying this option will vest on January 1, 2019, subject to the terms and conditions of the award and the 2012 Plan. The remainder of the shares of common stock underlying this option will vest pro rata on a monthly basis after the initial vesting date through January 1, 2022 (representing the vesting on each such vesting date of approximately 2.0833% of the shares of common stock initially underlying this option), subject to the terms and conditions of the award and the 2012 Plan."}],"balance_after":10500,"derivative":{"exercise_price":58.74,"expiration_date":"2028-02-05","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001144204-18-010357","document":"tv486820_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418010357/tv486820_4.xml","form_type":"4"}},{"id":4039911,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-02-22T21:00:34.000Z","date":"2018-02-05","kind":"grant","acquired":true,"shares":6900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying restricted stock units (\"RSUs\") granted on February 5, 2018, with each RSU representing the contingent right to receive one share of common stock upon vesting of the RSU. 25% of the shares of common stock underlying these RSUs will vest on January 1, 2019, subject to the terms and conditions of the award and the Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan (the \"2012 Plan\"). The remainder of the shares of common stock underlying the RSUs will vest pro rata on every subsequent three-month anniversary of the initial vesting date through January 1, 2022 (representing the vesting on each such vesting date of 6.25% of the shares of common stock initially underlying these RSUs), subject to the terms and conditions of the award and the 2012 Plan."}],"balance_after":27115,"source":{"system":"sec-edgar","filing":"0001144204-18-010357","document":"tv486820_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418010357/tv486820_4.xml","form_type":"4"}},{"id":4191940,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-10-04T21:02:19.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":354,"price":58.8326,"value":20826.7404,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each employee of the Issuer who has received restricted stock awards has agreed to a mandatory sale of a sufficient number of shares of common stock to cover his or her withholding tax amounts upon the vesting of such restricted stock awards. The sales denoted here were made pursuant to such agreement to cover withholding tax obligations of the employee."}],"balance_after":20215,"source":{"system":"sec-edgar","filing":"0001144204-17-051416","document":"v476463_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417051416/v476463_4.xml","form_type":"4"}},{"id":4263792,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-07-05T21:02:05.000Z","date":"2017-07-03","kind":"sale","acquired":false,"shares":1431,"price":121.5927,"value":173999.1537,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each employee of the Issuer who has received restricted stock awards has agreed to a mandatory sale of a sufficient number of shares of common stock to cover his or her withholding tax amounts upon the vesting of such restricted stock awards. The sales denoted here were made pursuant to such agreement to cover withholding tax obligations of the employee."}],"balance_after":20569,"source":{"system":"sec-edgar","filing":"0001144204-17-035813","document":"v470324_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417035813/v470324_form4.xml","form_type":"4"}},{"id":4468262,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2017-02-03T21:01:18.000Z","date":"2017-02-01","kind":"grant","acquired":true,"shares":11600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares of common stock underlying this option will vest on July 1, 2018, subject to the terms and conditions of the award and the 2012 Plan. The remainder of the shares of common stock underlying this option will vest pro rata on a monthly basis after the initial vesting date through July 1, 2021 (representing the vesting on each such vesting date of approximately 2.0833% of the shares of common stock initially underlying this option), subject to the terms and conditions of the award and the 2012 Plan."}],"balance_after":11600,"derivative":{"exercise_price":107.18,"expiration_date":"2027-07-01","underlying":"Common Stock","underlying_shares":11600},"source":{"system":"sec-edgar","filing":"0001144204-17-006033","document":"v458367_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417006033/v458367_4.xml","form_type":"4"}},{"id":4468261,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-03T21:01:18.000Z","date":"2017-02-01","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"25% of the shares of restricted stock will vest on July 1, 2018, subject to the terms and conditions of the award and the Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan (the \"2012 Plan\"). The remaining shares of restricted stock will vest pro rata on every subsequent three-month anniversary of the initial vesting date through July 1, 2021 (representing the vesting on each such vesting date of 6.25% of the shares of restricted stock), subject to the terms and conditions of the award and the 2012 Plan."}],"balance_after":22000,"source":{"system":"sec-edgar","filing":"0001144204-17-006033","document":"v458367_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417006033/v458367_4.xml","form_type":"4"}}]}